Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-07

Clinical Trial Update: Warfarine in Unexplained Oligohydramnios [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for warfarine in unexplained oligohydramnios has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • warfarine (warfarine)

Snippet

Sponsor: Woman's Health University Hospital, Egypt | Conditions: Oligohydramnios | Phase 4 | Status: TERMINATED